112 related articles for article (PubMed ID: 1738289)
1. Oncofetal antigen expression in head and neck carcinoma.
Gussack GS
Laryngoscope; 1992 Feb; 102(2):168-76. PubMed ID: 1738289
[TBL] [Abstract][Full Text] [Related]
2. 44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers.
Coggin JH; Rohrer SD; Hester RD; Barsoum AL; Rashid HU; Gussack GS
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1257-66. PubMed ID: 8217085
[TBL] [Abstract][Full Text] [Related]
3. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Heo DS; Snyderman C; Gollin SM; Pan S; Walker E; Deka R; Barnes EL; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1989 Sep; 49(18):5167-75. PubMed ID: 2766286
[TBL] [Abstract][Full Text] [Related]
4. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
Kienstra MA; Neel HB; Strome SE; Roche P
Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
[TBL] [Abstract][Full Text] [Related]
5. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
[TBL] [Abstract][Full Text] [Related]
7. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
9. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
[TBL] [Abstract][Full Text] [Related]
10. Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas.
Ravindranath NM; Shuler C
J Oral Pathol Med; 2006 Oct; 35(9):560-7. PubMed ID: 16968237
[TBL] [Abstract][Full Text] [Related]
11. Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck.
Lee KD; Chang HK; Jo YK; Kim BS; Lee BH; Lee YW; Lee HK; Huh MH; Min YG; Spagnoli GC; Yu TH
Anticancer Res; 1999; 19(6B):5037-42. PubMed ID: 10697507
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
[TBL] [Abstract][Full Text] [Related]
13. Human squamous cell carcinoma lines express oncofetal 44-kD polypeptide defined by monoclonal antibody to mouse fetus.
Gussack GS; Rohrer SD; Hester RB; Liu PI; Coggin JH
Cancer; 1988 Jul; 62(2):283-90. PubMed ID: 3289728
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
15. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
16. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
Fantozzi RD
Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.
Kass ES; Greiner JW; Kantor JA; Tsang KY; Guadagni F; Chen Z; Clark B; De Pascalis R; Schlom J; Van Waes C
Cancer Res; 2002 Sep; 62(17):5049-57. PubMed ID: 12208760
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
[TBL] [Abstract][Full Text] [Related]
19. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
[TBL] [Abstract][Full Text] [Related]
20. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
